Cargando…

Efficacy and quality of life of Romiplostim in adults and children with immune thrombocytopenia: A review

To systematically evaluate the clinical efficacy, drug safety and health-related quality of life (HRQoL) of Romiplostim in adult and child immune thrombocytopenia (ITP) patients. METHODS: PubMed, EMBASE and Cohrane library databases were searched for all randomized controlled trials published until...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Xin, Ran, Ningyuan, Wang, Ting, Shao, Zonghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	4800
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771258/ https://www.ncbi.nlm.nih.gov/pubmed/36550870 http://dx.doi.org/10.1097/MD.0000000000032345

Ejemplares similares

Long-term complications of splenectomy in adult immune thrombocytopenia
por: Thai, Lan-Huong, et al.
Publicado: (2016)

Contribution of interleukin 27 serum level to pathogenesis and prognosis in children with immune thrombocytopenia
por: Hassan, Tamer, et al.
Publicado: (2022)

Efficacy and Safety of Biosimilar Romiplostim Versus Innovator Romiplostim in Patients with Chronic Immune Thrombocytopenia
por: Chandrakala, S., et al.
Publicado: (2022)

Gene mutations in the PI3K/Akt signaling pathway were related to immune thrombocytopenia pathogenesis
por: Ruan, Jing-Shu, et al.
Publicado: (2023)

Immune thrombocytopenia associated with Hashimoto thyroiditis in a pediatric patient: A case report
por: Tian, Zhiqing, et al.
Publicado: (2021)

Safety and efficacy of romiplostim in children and adolescents with Immune thrombocytopenia: A systematic review
por: de Oliveira, Fernanda Lubiana, et al.
Publicado: (2023)

Correction to: Efficacy and Safety of Biosimilar Romiplostim Versus Innovator Romiplostim in Patients with Chronic Immune Thrombocytopenia
por: Chandrakala, S., et al.
Publicado: (2023)

Immunological characteristics and effect of cyclosporin in patients with immune thrombocytopenia
por: Wang, Ting, et al.
Publicado: (2021)

Whole exome sequencing for diagnosis of hereditary thrombocytopenia
por: Mekchay, Ponthip, et al.
Publicado: (2020)

Long-term safety and efficacy of romiplostim for treatment of immune thrombocytopenia
por: Vishnu, Prakash, et al.
Publicado: (2016)

JAK2 V617F-positive essential thrombocythemia with subsequent development of immune thrombocytopenia: A case report
por: Oda, Yasuhiro, et al.
Publicado: (2019)

Successful sirolimus therapy of an aplastic anemia patient with chronic kidney disease: A case report
por: Niu, Haiyue, et al.
Publicado: (2020)

A gene missense mutation in diffuse pulmonary lymphangiomatosis with thrombocytopenia: A case report
por: Zheng, Guixian, et al.
Publicado: (2020)

Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia
por: Grainger, John D., et al.
Publicado: (2021)

The role of romiplostim for pediatric patients with immune thrombocytopenia
por: Al-Samkari, Hanny, et al.
Publicado: (2020)

Romiplostim use in pregnant women with immune thrombocytopenia
por: Bussel, James B., et al.
Publicado: (2022)

Effects of microRNA-21 on apoptosis by regulating the expression of PTEN in diffuse large B-cell lymphoma
por: Song, Jia, et al.
Publicado: (2017)

Romiplostim as a treatment for immune thrombocytopenia: a review
por: Chalmers, Sarah, et al.
Publicado: (2015)

Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia
por: Cines, Douglas B., et al.
Publicado: (2017)

Parvovirus B19 infection presenting with neutropenia and thrombocytopenia: Three case reports
por: Shin, Hyoshim, et al.
Publicado: (2019)

Immature platelet fraction: A useful marker for identifying the cause of thrombocytopenia and predicting platelet recovery
por: Jeon, Kibum, et al.
Publicado: (2020)

Romiplostim as early treatment of immune thrombocytopenia with severe immunodeficiency
por: Palandri, Francesca, et al.
Publicado: (2012)

Role of romiplostim in splenectomized and nonsplenectomized patients with immune thrombocytopenia
por: Perdomo, Jose
Publicado: (2016)

New synergistic efficacy of combination of romiplostim and steroid in refractory immune thrombocytopenia patients
por: Yoon, Jun Seok, et al.
Publicado: (2018)

Once-weekly bortezomib had similar effectiveness and lower thrombocytopenia occurrence compared with twice-weekly bortezomib regimen in treating patients with newly diagnosed multiple myeloma in China
por: Yao, Rongxin, et al.
Publicado: (2019)

De-escalation empirical antibiotic therapy improved survival for patients with severe aplastic anemia treated with antithymocyte globulin
por: Fu, Rong, et al.
Publicado: (2017)

Successful eltrombopag treatment of severe refractory thrombocytopenia in chronic myelomonocytic leukemia: Two cases reports: A CARE-compliant article
por: Gao, Yayue, et al.
Publicado: (2017)

Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia
por: Soff, Gerald A., et al.
Publicado: (2019)

Reduced corticosteroid use in adult patients with primary immune thrombocytopenia receiving romiplostim
por: Michel, Marc, et al.
Publicado: (2011)

Intravascular large b-cell lymphoma diagnosed via transjugular liver biopsy in a patient with liver dysfunction and thrombocytopenia: A Case Report
por: Kim, Mi-Jung, et al.
Publicado: (2017)

A single-arm, long-term efficacy and safety study of subcutaneous romiplostim in children with immune thrombocytopenia
por: Grainger, John, et al.
Publicado: (2022)

Romiplostim for chemotherapy‐induced thrombocytopenia: Efficacy and safety of extended use
por: Wilkins, Cy R., et al.
Publicado: (2022)

Hemoglobin Hornchurch [β43 (CD2) Glu > Lys; HBB: c.130G > A] in a Chinese boy complicated with thrombocytopenia: A case report and literature review
por: Shi, Huiping, et al.
Publicado: (2017)

Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia
por: Janssens, Ann, et al.
Publicado: (2016)

Myelofibrosis Associated with Romiplostim Treatment in a Patient with Immune Thrombocytopenia
por: Gonzalez, Maria Fernanda, et al.
Publicado: (2012)

Cost Effectiveness of Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in Ireland
por: Lee, Dawn, et al.
Publicado: (2013)

Romiplostim for the Emergency Management of Severe Immune Thrombocytopenia with Intracerebral Hemorrhage
por: Gellens, Romain, et al.
Publicado: (2018)

Treatment of 5 dogs with immune-mediated thrombocytopenia using Romiplostim
por: Kohn, Barbara, et al.
Publicado: (2016)

Romiplostim and Eltrombopag in Immune Thrombocytopenia as a Second-Line Treatment
por: Bidika, Erjola, et al.
Publicado: (2020)

Neutropenia following intravenous immunoglobulin therapy in adult patients with immune thrombocytopenic purpura: A single center experience and literature review
por: Oh, Sang-Bo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t95fmq817e93fo0cecvtetm5s8